Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma
about
The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation.Treatment of recurrent hepatocellular carcinoma after liver transplantation.Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation.Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosisImproving Outcomes with Surgical Resection and Other Ablative Therapies in HCC.Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma.Independent prognostic factors for posttransplant survival in hepatocellular carcinoma patients undergoing liver transplantation.Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway.Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.Recent topics on α-fetoprotein.Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.
P2860
Q27300764-723DDE29-9EAB-4FB8-86C0-0895B1CA15BFQ27692523-D893E10E-1619-4A51-8A7C-34D9F38027F7Q33869846-5B1483AA-2A19-4CC8-956A-FC724930CC79Q33905617-C7CEB330-BF98-41B9-BE25-A5B15B326763Q34201437-04D51BBA-87D8-45B9-BC03-0BDE35A7B5B8Q34510569-56FBB015-6A42-411C-AB88-E3329A3D403BQ35207762-D407FE2E-E776-4DE5-8AE6-25A5476333E5Q35779474-73470E1E-AB9D-4186-B384-06674E116FD7Q37035208-674E8EC5-5DD0-4242-9ED2-6A8F2AD931A2Q37204902-022FDF1D-69AF-4A78-8959-65E0F657829BQ37609440-B7420D0A-5209-4CB5-9014-D3CA07C2C67DQ37895618-BF3FD160-BAC1-47DE-B58A-1DDA9423ADD5Q41017463-CA2F9C3E-8732-41C7-8F03-C5EBE0C69990Q43916781-593574B8-7CC0-4937-B8B5-C2E5928ABB76Q44119630-20AA5C9C-0AE9-4B19-8ECE-82F9D8076E03Q53123123-E8310F9A-EAFC-4CBE-9079-34E460B12462Q54558691-0425063B-83F1-4283-82C5-16B39C18EFA0
P2860
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@en
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@nl
type
label
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@en
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@nl
prefLabel
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@en
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@nl
P2093
P2860
P356
P1476
Prognostic factors for tumor r ...... with hepatocellular carcinoma
@en
P2093
Alessandro Dazzi
Antonietta D'Errico-Grigioni
Antonio Daniele Pinna
Augusto Lauro
Gaetano Vetrone
Gian Luca Grazi
Giorgio Ercolani
Marco Vivarelli
Massimo Del Gaudio
Matteo Cescon
P2860
P304
P356
10.1155/2010/904152
P577
2010-08-25T00:00:00Z